Paramivir is a synthetic cyclopentane derivative. Functional groups which get connected to the loop include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four functional groups with different polarities act on different active site regions in the NA structure of influenza viruses. This medicine is suitable for the treatment of influenza A. It is mainly administered intravenously in the form of sodium chloride solution.
This report contains market size and forecasts of Peramivir in global, including the following market information:
Global Peramivir Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peramivir Market Sales, 2017-2022, 2023-2028, (Kilotons)
Global top five Peramivir companies in 2021 (%)
The global Peramivir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals and Hunan Nucien Pharmaceutical Co., Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peramivir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peramivir Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, by Type, 2021 (%)
Solution
Solid
Global Peramivir Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, by Application, 2021 (%)
Influenza A Treatment
Influenza B Treatment
Global Peramivir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peramivir revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peramivir revenues share in global market, 2021 (%)
Key companies Peramivir sales in global market, 2017-2022 (Estimated), (Kilotons)
Key companies Peramivir sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma